Search

Search Constraints

You searched for: Author/Creator Sergeeva, Maria

Search Results

1. Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up. (August 2022)

2. Egg‐ or cell culture‐derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines. Issue 3 (10th December 2013)

4. Rapid spread of influenza A(H1N1)pdm09 viruses with a new set of specific mutations in the internal genes in the beginning of 2015/2016 epidemic season in Moscow and Saint Petersburg (Russian Federation). Issue 4 (27th May 2016)

5. Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan. (September 2021)

6. The role of Tween 80 and SDS in the kinetics of semi-clathrate hydrates formation for carbon dioxide capture from flue gas. Issue 10 (3rd July 2022)